prazosin hydrochloride

Generic: prazosin hydrochloride

Labeler: asclemed usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name prazosin hydrochloride
Generic Name prazosin hydrochloride
Labeler asclemed usa inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

prazosin hydrochloride 5 mg/1

Manufacturer
ASCLEMED USA INC.

Identifiers & Regulatory

Product NDC 76420-526
Product ID 76420-526_412ebee3-8ea7-9e7a-e063-6394a90aa63a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215697
Listing Expiration 2026-12-31
Marketing Start 2023-01-03

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420526
Hyphenated Format 76420-526

Supplemental Identifiers

RxCUI
198141 312593 312594
UNII
X0Z7454B90

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name prazosin hydrochloride (source: ndc)
Generic Name prazosin hydrochloride (source: ndc)
Application Number ANDA215697 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (76420-526-01)
  • 10 CAPSULE in 1 BOTTLE (76420-526-10)
  • 20 CAPSULE in 1 BOTTLE (76420-526-20)
  • 30 CAPSULE in 1 BOTTLE (76420-526-30)
  • 60 CAPSULE in 1 BOTTLE (76420-526-60)
  • 90 CAPSULE in 1 BOTTLE (76420-526-90)
source: ndc

Packages (6)

76420-526-01 100 CAPSULE in 1 BOTTLE (76420-526-01) 76420-526-10 10 CAPSULE in 1 BOTTLE (76420-526-10) 76420-526-20 20 CAPSULE in 1 BOTTLE (76420-526-20) 76420-526-30 30 CAPSULE in 1 BOTTLE (76420-526-30) 76420-526-60 60 CAPSULE in 1 BOTTLE (76420-526-60) 76420-526-90 90 CAPSULE in 1 BOTTLE (76420-526-90)

Ingredients (1)

prazosin hydrochloride (5 mg/1)

Linked Drug Pages (1)

prazosin hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "412ebee3-8ea7-9e7a-e063-6394a90aa63a", "openfda": {"unii": ["X0Z7454B90"], "rxcui": ["198141", "312593", "312594"], "spl_set_id": ["b66d105b-be78-4e54-9c01-b38e36ad74de"], "manufacturer_name": ["ASCLEMED USA INC."]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (76420-526-01)", "package_ndc": "76420-526-01", "marketing_start_date": "20251015"}, {"sample": false, "description": "10 CAPSULE in 1 BOTTLE (76420-526-10)", "package_ndc": "76420-526-10", "marketing_start_date": "20251015"}, {"sample": false, "description": "20 CAPSULE in 1 BOTTLE (76420-526-20)", "package_ndc": "76420-526-20", "marketing_start_date": "20251015"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (76420-526-30)", "package_ndc": "76420-526-30", "marketing_start_date": "20251015"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (76420-526-60)", "package_ndc": "76420-526-60", "marketing_start_date": "20251015"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (76420-526-90)", "package_ndc": "76420-526-90", "marketing_start_date": "20251015"}], "brand_name": "prazosin hydrochloride", "product_id": "76420-526_412ebee3-8ea7-9e7a-e063-6394a90aa63a", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "76420-526", "generic_name": "prazosin hydrochloride", "labeler_name": "ASCLEMED USA INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "prazosin hydrochloride", "active_ingredients": [{"name": "PRAZOSIN HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA215697", "marketing_category": "ANDA", "marketing_start_date": "20230103", "listing_expiration_date": "20261231"}